Search for: "PFIZER" Results 4421 - 4440 of 4,584
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Apr 2007, 7:30 am
Robert Temple, director of the FDA's Offices of Drug Evaluation, said his agency is "not particularly worried" about Dostinex:The two studies, published in January in the New England Journal of Medicine, also tied another Parkinson's drug, Pfizer Inc.'s Dostinex, or cabergoline, to heart-valve problems. [read post]
4 Apr 2007, 6:00 am
Reply Brief on the Merits (filed 02/22/07) Amicus Curiae Brief of Pacific Legal Foundation (submitted 03/23/07; filed 04/04/07) Amicus Curiae Brief of Consumer Attorneys of California (submitted 03/26/07) Amicus Curiae Brief of Pfizer, Inc. [read post]
3 Apr 2007, 6:51 am
Bloomberg reports that Pfizer is premiering a two-and-a-half-minute commercial (via Childs) for its COX-2 Celebrex that acknowledges that all NSAIDs have cardiovascular risks, and then argues that the benefits of Celebrex exceed the risks. [read post]
3 Apr 2007, 3:49 am
I'm not going to say much about it since I'm involved in other Cox-2 litigation, but coverage of the new Pfizer ads for Celebrex certainly are interesting, as is the ad itself. [read post]
1 Apr 2007, 7:39 am
The world's largest drug maker, Pfizer Inc., submitted pregabalin to the Food and Drug Administration in October. [read post]
30 Mar 2007, 9:48 am
The district court dismissed Teva's declaratory judgment action using the Fed Circuit’s earlier two prong “reasonable-apprehension-of-imminent-suit” test from Pfizer in stating that Teva had failed to establish a reasonable apprehension of imminent suit and that the district court therefore lacked jurisdiction over the declaratory judgment action. [read post]
30 Mar 2007, 9:36 am
More than a dozen other companies, such as Tyco, Pfizer, JP Morgan Chase, and Intel, have joined AFSCME, TIAA-CREF, F&C Asset Management, Hermes, and other institutional investors in a working group to discuss the issue. [read post]
27 Mar 2007, 10:27 am
  Not to mention the Pacific Research Institute itself, whose major contributors include Altria, Pfizer, and Microsoft. [read post]
27 Mar 2007, 8:14 am
  Mylan launched its generic Norvasc last week and, with the exception of Pfizer's authorized generic, currently has the only generic on the market. [read post]
26 Mar 2007, 9:38 am
Recent approvals of follow-on biologics by the FDA have been limited to those few biotechnologically derived products such as human growth hormone and certain insulin products approved under the New Drug Approval provisions of the Food, Drug, and Cosmetic Act, such as Novartis' Sandoz approval of a 505(b)(2) NDA for its Omnitrope ® version of Pfizer's Genotropin ® human growth hormone. [read post]
25 Mar 2007, 9:46 pm
Pfizer had beaten Mylan over Norvasc and Pfizer had beaten Apotex over Norvasc, BUT the CAFC has determined claims covering Norvasc are obvious in the case Pfizer v. [read post]